Rosa M. Tolon

Pozuelo De Alarcon, MD 28223, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Resilience and susceptibility to fear extinction are associated with alterations in neurogenesis and brain-wide activity.

Resilience and susceptibility to fear extinction are associated with alterations in neurogenesis and brain-wide activity.

Journal: Neurobiology of disease

Published: December 12, 2025

Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice.

Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice.

Journal: iScience

Published: October 18, 2024

Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics.

Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics.

Journal: Translational psychiatry

Published: August 12, 2024

Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease.

Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: March 26, 2021

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.

Journal: Blood

Published: February 27, 2020

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease.

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease.

Journal: Biochemical pharmacology

Published: June 21, 2018

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.

Journal: Biochemical pharmacology

Published: June 04, 2018

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: January 11, 2018

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.

Journal: Journal of neurology

Published: February 22, 2016

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

Journal: Neurobiology of disease

Published: July 31, 2014

Endocannabinoid regulation of amyloid-induced neuroinflammation.

Endocannabinoid regulation of amyloid-induced neuroinflammation.

Journal: Neurobiology of aging

Published: January 07, 2014

β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.

β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.

Journal: British journal of pharmacology

Published: February 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026